期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Stereotactic radiosurgery for haemorrhagic cerebral cavernous malformation:a multi-institutional,retrospective study
1
作者 Chloe Dumot Georgios Mantziaris +33 位作者 Sam Dayawansa Zhiyuan Xu Stylianos Pikis Selcuk Peker Yavuz Samanci Gokce D Ardor Ahmed M Nabeel Wael A Reda Sameh R Tawadros khaled abdelkarim Amr M N El-Shehaby Reem M Emad Eldin Ahmed H Elazzazi Nuria Martínez Moreno Roberto MartínezÁlvarez Roman Liscak Jaromir May David Mathieu Jean-Nicolas Tourigny Manjul Tripathi Akshay Rajput Narendra Kumar Rupinder Kaur Piero Picozzi Andrea Franzini Herwin Speckter Wenceslao Hernandez Anderson Brito Ronald E Warnick Juan Alzate Douglas Kondziolka Greg N Bowden Samir Patel Jason Sheehan 《Stroke & Vascular Neurology》 SCIE CSCD 2024年第3期221-229,I0130,I0131,共11页
Background Cerebral cavernous malformations(CCMs)frequently manifest with haemorrhages.Stereotactic radiosurgery(SRS)has been employed for CCM not suitable for resection.Its effect on reducing haemorrhage risk is stil... Background Cerebral cavernous malformations(CCMs)frequently manifest with haemorrhages.Stereotactic radiosurgery(SRS)has been employed for CCM not suitable for resection.Its effect on reducing haemorrhage risk is still controversial.The aim of this study was to expand on the safety and efficacy of SRS for haemorrhagic CCM.Methods This retrospective multicentric study included CCM with at least one haemorrhage treated with single-session SRS.The annual haemorrhagic rate(AHR)was calculated before and after SRS.Recurrent event analysis and Cox regression were used to evaluate factors associated with haemorrhage.Adverse radiation effects(AREs)and occurrence of new neurological deficits were recorded.Results The study included 381 patients (median age:37.5 years(Q1–Q3:25.8–51.9))with 414 CCMs.The AHR from diagnosis to SRS excluding the first haemorrhage was 11.08 per 100 CCM-years and was reduced to 2.7 per 100 CCM-years after treatment.In recurrent event analysis,SRS,HR 0.27(95%CI 0.17 to 0.44),p<0.0001 was associated with a decreased risk of haemorrhage,and the presence of developmental venous anomaly(DVA)with an increased risk,HR 1.60(95%CI 1.07 to 2.40),p=0.022.The cumulative risk of first haemorrhage after SRS was 9.4%(95%CI 6%to 12.6%)at 5 years and 15.6%(95%CI%9 to 21.8%)at 10 years.Margin doses>13 Gy,HR 2.27(95%CI 1.20 to 4.32),p=0.012 and the presence of DVA,HR 2.08(95%CI 1.00 to 4.31),p=0.049 were factors associated with higher probability of post-SRS haemorrhage.Post-SRS haemorrhage was symptomatic in 22 out of 381(5.8%)patients,presenting with transient(15/381)or permanent(7/381)neurological deficit.ARE occurred in 11.1%(46/414)CCM and was responsible for transient neurological deficit in 3.9%(15/381)of the patients and permanent deficit in 1.1%(4/381)of the patients.Margin doses>13 Gy and CCM volume>0.7 cc were associated with increased risk of ARE. 展开更多
关键词 doses haemorrhagic DIAGNOSIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部